Patients with juvenile idiopathic arthritis become adults: the role of transitional care

Juvenile Idiopathic Arthritis

Outcome of transition phase patients with juvenile idiopathic arthritis

Mod Rheumatol.

Relas H, Luosujärvi R, Kosola S

Juvenile Idiopathic Arthritis

Treatment Satisfaction with and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients with Juvenile Idiopathic Arthritis

Arthritis Care Res (Hoboken).

Tollisen A, Flatø B, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A

doi: 10.1002/acr.24113.

Juvenile Idiopathic Arthritis

Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort

Arthritis Care Res (Hoboken).

Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Toftedal P, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T, Nordic Study Group of Pediatric Rheumatology (NoSPeR)

doi: 10.1002/acr.23853.

Spinal Disorders

Clinical Team Perspectives on the Psychosocial Aspects of Transition to Adult Care for Patients with Childhood-Onset Systemic Lupus Erythematosus

Arthritis Care Res (Hoboken)

Bitencourt N, Kramer J, Bermas BL, Solow EB, Wright T, Makris UE

doi: 10.1002/acr.24463

Juvenile Idiopathic Arthritis

Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study

Rheumatology (Oxford).

Heiligenhaus A, Klotsche J, Tappeiner C, Sengler C, Niewerth M, Liedmann I, Hoeft S, Walscheid K, Lavric M, Foell D, Minden K

doi: 10.1093/rheumatology/key406.

Juvenile Idiopathic Arthritis

Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership

Rheumatology (Oxford).

McErlane F, Foster HE, Armitt G, Bailey K, Cobb J, Davidson JE, Douglas S, Fell A, Friswell M, Pilkington C, Strike H, Smith N, Thomson W, Cleary G

doi: 10.1093/rheumatology/kex322.

Juvenile Idiopathic Arthritis

Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis

Arthritis Care Res (Hoboken).

Brunner HI, Chen C, Bovis F, De Benedetti F, Espada G, Joos R, Akikusa J, Chaitow J, Boteanu AL, Kimura Y, Rietschel C, Siri D, Smolewska E, Schmeling H, Brown DE, Martini A, Lovell DJ, Huang B, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

doi: 10.1002/acr.24384.

Juvenile Idiopathic Arthritis

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Arthritis Res Ther.

Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I, Trauzeddel R, Ganser G, Weller-Heinemann F, Haas JP

doi: 10.1186/

Juvenile Idiopathic Arthritis

The role of imaging in juvenile idiopathic arthritis

Expert Rev Clin Immunol.

Malattia C, Rinaldi M, Martini A

doi: 10.1080/1744666X.

Related content

Outcome of transition phase patients with juvenile idiopathic arthritis

Treatment Satisfaction with and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients with Juvenile Idiopathic Arthritis

Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort

Clinical Team Perspectives on the Psychosocial Aspects of Transition to Adult Care for Patients with Childhood-Onset Systemic Lupus Erythematosus

Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study

Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership

Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

The role of imaging in juvenile idiopathic arthritis